Epalrestat
Epalrestat CAS nr .: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat er notað til að koma í veg fyrir, bæta og meðhöndla útlæga taugakvilla (dofa, sársauka), titringsstíflu og óeðlilegt hjarta í tengslum við sykursýki. FORSKRIFT
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat er notað til að koma í veg fyrir, bæta og meðhöndla útlæga taugakvilla (dofa, sársauka), titringsstíflu og óeðlilegt hjarta í tengslum við sykursýki. FORSKRIFT
| P roduct nafn | Epalrestat |
| CAS | 82159-09-9 |
| MF: | C15H13NO3S2 |
| MW: | 319.4 |
Skrifaðu skilaboðin þín hér og sendu okkur
